Fingerprint
Dive into the research topics of 'Phase III Study to Evaluate Efficacy and Safety of Andecaliximab with mFOLFOX6 as First-Line Treatment in Patients with Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically